Oscar Health, Inc. (NYSE:OSCR) CFO Sells $511,066.42 in Stock

Oscar Health, Inc. (NYSE:OSCR) CFO Richard Scott Blackley sold 29,957 shares of Oscar Health stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $17.06, for a total value of $511,066.42. Following the sale, the chief financial officer now directly owns 853,875 shares in the company, valued at $14,567,107.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Richard Scott Blackley also recently made the following trade(s):

• On Tuesday, September 3rd, Richard Scott Blackley sold 68,978 shares of Oscar Health stock. The shares were sold at an average price of $17.99, for a total value of $1,240,914.22.

Oscar Health Price Performance

Oscar Health stock opened at $20.67 on Thursday. The stock’s 50 day moving average is $17.10 and its 200 day moving average is $17.27. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.91 and a quick ratio of 0.91. The firm has a market cap of $4.90 billion, a P/E ratio of -51.68, a P/E/G ratio of 33.66 and a beta of 1.61. Oscar Health, Inc. has a one year low of $4.72 and a one year high of $23.44.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, topping analysts’ consensus estimates of $0.16 by $0.04. The company had revenue of $2.20 billion for the quarter, compared to analyst estimates of $2.13 billion. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The firm’s quarterly revenue was up 44.6% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.07) earnings per share. As a group, research analysts expect that Oscar Health, Inc. will post 0.01 EPS for the current year.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Wells Fargo & Company lifted their price target on Oscar Health from $24.00 to $27.00 and gave the company an “overweight” rating in a research note on Wednesday, June 12th. Baird R W raised Oscar Health to a “strong-buy” rating in a research note on Thursday, May 30th. Bank of America reissued a “neutral” rating and set a $21.00 price target (down from $25.00) on shares of Oscar Health in a research note on Thursday, May 30th. Piper Sandler reissued an “overweight” rating and set a $28.00 price target on shares of Oscar Health in a research note on Tuesday. Finally, Robert W. Baird assumed coverage on Oscar Health in a research note on Thursday, May 30th. They issued an “outperform” rating and a $28.00 price objective on the stock. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $24.17.

Institutional Investors Weigh In On Oscar Health

A number of hedge funds have recently added to or reduced their stakes in OSCR. New York State Common Retirement Fund increased its holdings in Oscar Health by 3.8% in the fourth quarter. New York State Common Retirement Fund now owns 64,856 shares of the company’s stock worth $593,000 after purchasing an additional 2,394 shares in the last quarter. Victory Capital Management Inc. increased its holdings in Oscar Health by 37.7% in the fourth quarter. Victory Capital Management Inc. now owns 18,852 shares of the company’s stock worth $172,000 after purchasing an additional 5,159 shares in the last quarter. National Bank of Canada FI bought a new stake in Oscar Health in the fourth quarter worth approximately $1,071,000. Charles Schwab Investment Management Inc. increased its holdings in Oscar Health by 3.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,160,483 shares of the company’s stock worth $10,618,000 after purchasing an additional 35,128 shares in the last quarter. Finally, Teacher Retirement System of Texas bought a new stake in Oscar Health in the fourth quarter worth approximately $406,000. 75.70% of the stock is currently owned by institutional investors.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.